Browsing by Author Stathopoulos, P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 16 of 16
TitleAuthor(s)Issue date???itemlist.???
alpha AND beta-ASPARTYL PEPTIDE ESTERS FORMATION VIA ASPARTIMIDE RING OPENINGStathopoulos, P.; Papas, S.; Kostidis, S.; Tsikaris, V.24-Nov-2015-
alpha- and beta-Aspartyl peptide ester formation via aspartimide ring openingStathopoulos, P.; Papas, S.; Kostidis, S.; Tsikaris, V.24-Nov-2015-
Aspartyl methyl ester formation via aspartimide ring opening: a proposed modification of the protocols used in Boc- and Fmoc-based solid-phase peptide synthesisKostidis, S.; Stathopoulos, P.; Chondrogiannis, N. I.; Sakarellos, C.; Tsikaris, V.24-Nov-2015-
C-terminal N-alkylated peptide amides resulting from the linker decomposition of the Rink amide resin. A new cleavage mixture prevents their formationStathopoulos, P.; Papas, S.; Tsikaris, V.24-Nov-2015-
Cargo Delivery into Human Platelets Using the Tat(48-60) Cell-Penetrating PeptideTsikaris, E.; Stathopoulos, P.; Dimitriou, A.; Moussis, V.; Sakarellos-Daitsiotis, M.; Tsoukatos, D.; Tselepis, A. D.24-Nov-2015-
Effect of titanium maxillofacial implants and osteosynthesis materials on platelet functionStathopoulos, P.; Theodossiades, G.; Mourouzis, C.; Evangelou, A.24-Nov-2015-
Formation of C-terminal N-alkylated amide byproducts in Fmoc-based solid phase peptide synthesisPapas, S.; Stathopoulos, P.; Tsikaris, V.24-Nov-2015-
Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative studyTselepis, A. D.; Rodi, F. I.; Mitsios, J. V.; Stathopoulos, P.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Michalis, L. K.; Goudevenos, J. A.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Sideris, D. A.24-Nov-2015-
Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60)Dimitriou, A. A.; Stathopoulos, P.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Goudevenos, J.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Inhibition of platelet activation by peptide analogues of the intracellular domain of beta 3 subunit of the platelet integrin receptorDimitiou, A. A.; Stathopoulos, P.; Tsikaris, B.; Tselepis, A. D.24-Nov-2015-
The interleukin-1 beta gene polymorphism +3953 C/T is not associated with risk for oral cancerVairaktaris, E.; Serefoglou, Z.; Yapijakis, C.; Stathopoulos, P.; Vassiliou, S.; Derka, S.; Nkenke, E.; Vylliotis, A.; Ragos, V.; Neukam, F. W.; Patsouris, E.24-Nov-2015-
Mapping the Fibrinogen Binding Sites of the Platelet Receptor Using Synthetic Peptides Derived from the Beta 3 SubunitStathopoulos, P.; Rodis, F.; Naydenova, E.; Tsoukatos, D.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Peptide analogues derived from the cytoplasmic domain of alpha IIB beta 3 integrin receptor inhibit platelet aggregationKoloka, V.; Stathopoulos, P.; Panou-Pomonis, E.; Vaxevanellis, S.; Dimitriou, A.; Tsironis, L.; Tsoukatos, D.; Tselepis, A.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsikaris, V.24-Nov-2015-
Peptides Derived from Cytoplasmic Region of the Integrin Platelet Receptor as Anti-Aggregatory AgientsStathopoulos, P.; Koloka, V.; Rodis, F.; Mitsios, J.; Vaxevanellis, S.; Panou-Pomonis, E.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsoukatos, D.; Tselepis, A.; Tsikaris, V.24-Nov-2015-
Side reactions in the SPPS of Cys-containing peptidesStathopoulos, P.; Papas, S.; Pappas, C.; Mousis, V.; Sayyad, N.; Theodorou, V.; Tzakos, A. G.; Tsikaris, V.24-Nov-2015-
Unexpected Synthesis of an Unsymmetrical mu-Oxido Divanadium(V) Compound through a Reductive Cleavage of a N-O Bond and Cleavage-Hydrolysis of a C-N Bond of an N,N-Disubstituted Bis-(hydroxylamino) LigandNikolakis, V. A.; Stathopoulos, P.; Exarchou, V.; Gallos, J. K.; Kubicki, M.; Kabanos, T. A.24-Nov-2015-